Rong-Hwa Shyu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rong-Hwa Shyu has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Der-Jiang Chiao
National Defense Medical Center
5 shared publicationsJiunn-Jye Wey
National Defense Medical Center
4 shared publicationsPei-Yi Tsui
National Defense Medical Center
4 shared publicationsShiao-Shek Tang
Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China
3 shared publicationsChao-Yi Teng
1 shared publicationChein-Ming Hsei
1 shared publication
Latest Publications
- 1 January 2021
- Published by American Scientific Publishers in Materials Express
- Vol. 11 (1) , 63-72
Preparation of competitive immunochromatographic assay for detection of residual fipronil in urine and food samples
A colloidal silver nanoparticle (AgNP)-based lateral flow immunoassay (LFIA) was developed using an antifipronil polyclonal antibody (fAb), and its employment for the rapid detection of residual fipronil in spiked egg, honey, tea and human urine samples was studied. The fAb was successfully immobilized on the AgNP surface by ionic interactions and characterized using the Bradford method, UV-Vis, SEM, TEM and XPS analyses. The visible detection limit and optical detection limit of the fipronil test strip were 40 and 2.0 ppb, respectively, in fipronil standard solution. This assay showed no cross-reaction with pyraclofos or ethiprole. Finally, the fipronil test strip was effectively applied for the detection of fipronil spiked into egg, honey, tea and urine samples, with optical detection limits of 4.6, 10, 4.6 and 3.0 ppb, respectively. The results demonstrated that this assay is suitable for the quantitative detection of fipronil at trace levels in agricultural, food and urine samples.
- 1 January 2021
- Published by American Scientific Publishers in Materials Express
- Vol. 11 (1) , 63-72
Preparation of competitive immunochromatographic assay for detection of residual fipronil in urine and food samples
A colloidal silver nanoparticle (AgNP)-based lateral flow immunoassay (LFIA) was developed using an antifipronil polyclonal antibody (fAb), and its employment for the rapid detection of residual fipronil in spiked egg, honey, tea and human urine samples was studied. The fAb was successfully immobilized on the AgNP surface by ionic interactions and characterized using the Bradford method, UV-Vis, SEM, TEM and XPS analyses. The visible detection limit and optical detection limit of the fipronil test strip were 40 and 2.0 ppb, respectively, in fipronil standard solution. This assay showed no cross-reaction with pyraclofos or ethiprole. Finally, the fipronil test strip was effectively applied for the detection of fipronil spiked into egg, honey, tea and urine samples, with optical detection limits of 4.6, 10, 4.6 and 3.0 ppb, respectively. The results demonstrated that this assay is suitable for the quantitative detection of fipronil at trace levels in agricultural, food and urine samples.
- Open Access
- 14 August 2018
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 18 (1) , 1-12
Rapid and sensitive detection of Yersinia pestis by lateral-flow assay in simulated clinical samples
Yersinia pestis is a contributing agent to the epidemic disease, plague, which killed an estimated 200 million people during historical times. In this study, a rapid, cheap, sensitive, and specific technique, the lateral flow assay (F1 strips), has been successfully developed to detect this pathogen, by using paired monoclonal antibodies (MAbs) against Y. pestis capsule like fraction 1 (F1) protein. Compared with the polyclonal antibody (PAb) based F1 strips, the Mab-based F1 strips have a remarkable increased detection limitation (10 to 100 folds). Furthermore, besides the limitation and specificity evaluation, the application of this F1 strip on simulated clinical samples indicate the LFA can be a good candidate to detect plague. Recombinant F1 antigen was expressed and purified from a series of works. The various anti-F1 monoclonal antibodies generated from hybridoma cells were screened with the ELISA technique. To evaluate the feasibility of this Y. pestis F1 test strip, the F1 protein/Y. pestis was spiked into simulated clinical samples such as human serum, mouse bronchoalveolar lavage fluids, and mouse blood to mimic natural infection status. Additionally, this technique was applied to detect the Y. pestis in the environment-captured rats, to evaluate the practical usefulness of the strips. By using this MAb-based-LFA technique, 4 ng/ml of recombinant F1-protein and 103 CFU/ml of Y. pestis could be detected in less than 10 mins, which is at least 10-folds than that of the PAb format. On the other hand, although various Yersinia strains were applied to the strips, only Y. pestis strain showed a positive result; all other Yersinia species did not produce a positive signal, indicating the high efficiency and specificity of the MAb-based F1-strips. Based on our findings, we suggest that the MAb-format-LFA will be valuable as a diagnostic tool for the detection of Y. pestis. This report shows that the F1 strip is sufficient to support not only the detection of plague in simulated clinical samples, but also it may be a good candidate to meet the epidemiological surveillance during an outbreak of the biological warfare.
- 14 August 2018
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 18 (1) , 1-12
Open AccessRapid and sensitive detection of Yersinia pestis by lateral-flow assay in simulated clinical samples
Yersinia pestis is a contributing agent to the epidemic disease, plague, which killed an estimated 200 million people during historical times. In this study, a rapid, cheap, sensitive, and specific technique, the lateral flow assay (F1 strips), has been successfully developed to detect this pathogen, by using paired monoclonal antibodies (MAbs) against Y. pestis capsule like fraction 1 (F1) protein. Compared with the polyclonal antibody (PAb) based F1 strips, the Mab-based F1 strips have a remarkable increased detection limitation (10 to 100 folds). Furthermore, besides the limitation and specificity evaluation, the application of this F1 strip on simulated clinical samples indicate the LFA can be a good candidate to detect plague. Recombinant F1 antigen was expressed and purified from a series of works. The various anti-F1 monoclonal antibodies generated from hybridoma cells were screened with the ELISA technique. To evaluate the feasibility of this Y. pestis F1 test strip, the F1 protein/Y. pestis was spiked into simulated clinical samples such as human serum, mouse bronchoalveolar lavage fluids, and mouse blood to mimic natural infection status. Additionally, this technique was applied to detect the Y. pestis in the environment-captured rats, to evaluate the practical usefulness of the strips. By using this MAb-based-LFA technique, 4 ng/ml of recombinant F1-protein and 103 CFU/ml of Y. pestis could be detected in less than 10 mins, which is at least 10-folds than that of the PAb format. On the other hand, although various Yersinia strains were applied to the strips, only Y. pestis strain showed a positive result; all other Yersinia species did not produce a positive signal, indicating the high efficiency and specificity of the MAb-based F1-strips. Based on our findings, we suggest that the MAb-format-LFA will be valuable as a diagnostic tool for the detection of Y. pestis. This report shows that the F1 strip is sufficient to support not only the detection of plague in simulated clinical samples, but also it may be a good candidate to meet the epidemiological surveillance during an outbreak of the biological warfare.
- Open Access
- 21 May 2015
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 99 (18) , 7781-7789
Rapid detection of Yersinia pestis recombinant fraction 1 capsular antigen
Yersinia pestis, an infectious bacterium that is a causative agent of plague, a disease which has been shown to be one of the most feared in history and which has caused millions of deaths. The capsule-like fraction 1 (F1) antigen expressed by Y. pestis is a known specific marker for the identification of the bacteria; therefore, the detection of F1 is important for Y. pestis recognition. In this study, a rapid, sensitive, and specific technique, the lateral flow assay (LFA), was successfully developed to detect Y. pestis by the recombinant F1 antigen. The assay that utilized an anti-F1 polyclonal antibody (Pab) to identify the bacteria was based on a double-antibody sandwich format on a nitrocellulose membrane. With the LFA method, 50 ng/ml of recombinant F1 protein and 105 CFU/mL of Y. pestis could be detected in less than 10 min. This assay also showed no cross-reaction with other Yersinia spp. or with some selected capsule-producing Enterobacteriaceae strains. Furthermore, detection of Y. pestis in simulated samples has been evaluated. The detection sensitivity of Y. pestis in various matrices was 105 CFU/mL, which was identical to that in PBS buffer. The results obtained suggest that LFA is an excellent tool for detection of Y. pestis contamination in an environment and hence can be used to monitor plague diseases when they emerge.
- 21 May 2015
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 99 (18) , 7781-7789
Open AccessRapid detection of Yersinia pestis recombinant fraction 1 capsular antigen
Yersinia pestis, an infectious bacterium that is a causative agent of plague, a disease which has been shown to be one of the most feared in history and which has caused millions of deaths. The capsule-like fraction 1 (F1) antigen expressed by Y. pestis is a known specific marker for the identification of the bacteria; therefore, the detection of F1 is important for Y. pestis recognition. In this study, a rapid, sensitive, and specific technique, the lateral flow assay (LFA), was successfully developed to detect Y. pestis by the recombinant F1 antigen. The assay that utilized an anti-F1 polyclonal antibody (Pab) to identify the bacteria was based on a double-antibody sandwich format on a nitrocellulose membrane. With the LFA method, 50 ng/ml of recombinant F1 protein and 105 CFU/mL of Y. pestis could be detected in less than 10 min. This assay also showed no cross-reaction with other Yersinia spp. or with some selected capsule-producing Enterobacteriaceae strains. Furthermore, detection of Y. pestis in simulated samples has been evaluated. The detection sensitivity of Y. pestis in various matrices was 105 CFU/mL, which was identical to that in PBS buffer. The results obtained suggest that LFA is an excellent tool for detection of Y. pestis contamination in an environment and hence can be used to monitor plague diseases when they emerge.
- 18 July 2014
- Published by Springer Nature in Forensic Toxicology
- Vol. 32 (2) , 258-265
Comparison of immunostrips with mouse bioassay and bacterial culture in detecting botulinum toxins in bottles from suspected Taiwan high-speed rail bomber
- 18 July 2014
- Published by Springer Nature in Forensic Toxicology
- Vol. 32 (2) , 258-265
Comparison of immunostrips with mouse bioassay and bacterial culture in detecting botulinum toxins in bottles from suspected Taiwan high-speed rail bomber
- 1 December 2013
- Published by Elsevier in Food Chemistry
- Vol. 141 (3) , 1789-1795
Comparison of LFA with PCR and RPLA in detecting SEB from isolated clinical strains of Staphylococcus aureus and its application in food samples
- 1 December 2013
- Published by Elsevier in Food Chemistry
- Vol. 141 (3) , 1789-1795
Comparison of LFA with PCR and RPLA in detecting SEB from isolated clinical strains of Staphylococcus aureus and its application in food samples
- 1 April 2013
- Published by Elsevier in Journal of Virological Methods
- Vol. 189 (1) , 58-64
Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system
- 1 April 2013
- Published by Elsevier in Journal of Virological Methods
- Vol. 189 (1) , 58-64
Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system
- 1 January 2010
- Published by Elsevier in Food Chemistry
- Vol. 118 (2) , 462-466
Gold nanoparticle-based lateral flow assay for detection of staphylococcal enterotoxin B
- 1 January 2010
- Published by Elsevier in Food Chemistry
- Vol. 118 (2) , 462-466
Gold nanoparticle-based lateral flow assay for detection of staphylococcal enterotoxin B
- 1 February 2008
- Published by SAGE Publications in Hybridoma
- Vol. 27 (1) , 31-35
Monoclonal Antibody-Based Lateral Flow Assay for Detection of Botulinum Neurotoxin Type A
A rapid lateral flow assay was developed to detect botulinum neurotoxin type A (BoNT/A). The assay was based on the sandwich format using monoclonal antibodies (MAbs) of two distinct specificities. One anti-BoNT/A heavy chain MAb (150-3) was immobilized to a defined detection zone on a porous nitrocellulose membrane, while the other anti-BoNT/A heavy chain MAb (44.1) was conjugated to colloidal gold particles, which served as a detection reagent. The BoNT/A-containing sample was added to the strip and allowed to react with MAb (44.1)-coated particles. The mixture was then passed along the porous membrane by capillary action past the MAb (150-3) in the detection zone, which binds the particles that had BoNT/A bound to their surface, giving a red color within this detection zone with intensity proportional to BoNT/A concentration. In the absence of BoNT/A, no immunogold was bound to the solid-phase antibody. With this method, 50 ng/mL of BoNT/A were detected in less than 10 min. The assay sensitivity can be increased by silver enhancement to 1 ng/mL. The developed BoNT/A assay also showed no cross-reaction to type B neurotoxin (BoNT/B) and type E neurotoxin (BoNT/E).
- 1 February 2008
- Published by SAGE Publications in Hybridoma
- Vol. 27 (1) , 31-35
Monoclonal Antibody-Based Lateral Flow Assay for Detection of Botulinum Neurotoxin Type A
A rapid lateral flow assay was developed to detect botulinum neurotoxin type A (BoNT/A). The assay was based on the sandwich format using monoclonal antibodies (MAbs) of two distinct specificities. One anti-BoNT/A heavy chain MAb (150-3) was immobilized to a defined detection zone on a porous nitrocellulose membrane, while the other anti-BoNT/A heavy chain MAb (44.1) was conjugated to colloidal gold particles, which served as a detection reagent. The BoNT/A-containing sample was added to the strip and allowed to react with MAb (44.1)-coated particles. The mixture was then passed along the porous membrane by capillary action past the MAb (150-3) in the detection zone, which binds the particles that had BoNT/A bound to their surface, giving a red color within this detection zone with intensity proportional to BoNT/A concentration. In the absence of BoNT/A, no immunogold was bound to the solid-phase antibody. With this method, 50 ng/mL of BoNT/A were detected in less than 10 min. The assay sensitivity can be increased by silver enhancement to 1 ng/mL. The developed BoNT/A assay also showed no cross-reaction to type B neurotoxin (BoNT/B) and type E neurotoxin (BoNT/E).
- 1 September 2004
- Published by Elsevier in Journal of Chromatography B
- Vol. 809 (1) , 37-41
Colloidal gold-based immunochromatographic assay for detection of botulinum neurotoxin type B
- 1 September 2004
- Published by Elsevier in Journal of Chromatography B
- Vol. 809 (1) , 37-41
Colloidal gold-based immunochromatographic assay for detection of botulinum neurotoxin type B
- 15 September 2002
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 186 (6) , 743-751
Facilitation of Cell Adhesion by Immobilized Dengue Viral Nonstructural Protein 1 (NS1): Arginine‐Glycine‐Aspartic Acid Structural Mimicry within the Dengue Viral NS1 Antigen
Dengue virus infection causes life-threatening hemorrhagic fever. Increasing evidence implies that dengue viral nonstructural protein 1 (NS1) exhibits a tendency to elicit potentially hazardous autoantibodies, which show a wide spectrum of specificity against extracellular matrix and platelet antigens. How NS1 elicits autoantibodies remains unclear. To address the hypothesis that NS1 and matrix proteins may have structural and functional similarity, cell-matrix and cell-NS1 interactions were evaluated using a cell-adhesion assay. The present study showed that dengue NS1 immobilized on coverslips resulted in more cell adhesion than did the control proteins. This cell adhesion was inhibited by peptides containing arginine-glycine-aspartic acid (RGD), a motif important for integrin-mediated cell adhesion. In addition, anti-NS1 antibodies blocked RGD-mediated cell adhesion. Although there is no RGD motif in the NS1 protein sequence, these data indicate that RGD structural mimicry exists within the NS1 antigen.
- 15 September 2002
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 186 (6) , 743-751
Facilitation of Cell Adhesion by Immobilized Dengue Viral Nonstructural Protein 1 (NS1): Arginine‐Glycine‐Aspartic Acid Structural Mimicry within the Dengue Viral NS1 Antigen
Dengue virus infection causes life-threatening hemorrhagic fever. Increasing evidence implies that dengue viral nonstructural protein 1 (NS1) exhibits a tendency to elicit potentially hazardous autoantibodies, which show a wide spectrum of specificity against extracellular matrix and platelet antigens. How NS1 elicits autoantibodies remains unclear. To address the hypothesis that NS1 and matrix proteins may have structural and functional similarity, cell-matrix and cell-NS1 interactions were evaluated using a cell-adhesion assay. The present study showed that dengue NS1 immobilized on coverslips resulted in more cell adhesion than did the control proteins. This cell adhesion was inhibited by peptides containing arginine-glycine-aspartic acid (RGD), a motif important for integrin-mediated cell adhesion. In addition, anti-NS1 antibodies blocked RGD-mediated cell adhesion. Although there is no RGD motif in the NS1 protein sequence, these data indicate that RGD structural mimicry exists within the NS1 antigen.